Merck Serono again tries to FLEX Erbitux's muscle in NSCLC
30 March 2011
Alex Shimmings
Please Login to read the full article.
30 March 2011
Alex Shimmings
alex.shimmings@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- NICE decision puts down a marker for drug development
- Idera holds out hope for IMO-2055 after negative Phase II head and neck cancer data
- BMS discloses expanded Erbitux use rejected, new SEC probe
- Afatinib enters Phase III in head and neck cancer; expects to file in 2-3 years
ANALYSIS
Other Informa Analysis
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
